Cresco Labs Q3 2026 net loss narrows 34% year-over-year to USD 14.53 million

CRLBF•2026-11-06

Cresco Labs’ third-quarter 2026 net loss narrowed 34% year-over-year to USD 14.53 million, while revenue rose 5% to USD 172.78 million.

1. Quarterly results

Operating cash flow climbed 69% from the previous quarter to USD 26.13 million. During the quarter, Cresco Labs closed an acquisition, improved cultivation and ramped up operations in a new state.

Cresco Labs Q3 2026 net loss narrows 34% year-over-year to USD 14.53 million

1. Quarterly results

Related News

Vistra Q3 revenue $6,347 million vs. IBES estimate $6,024 million

NeoGenomics to participate in Stephens and Piper Sandler investor conferences

TeraWulf swings to Q3 2026 net profit of $709.53 million

Stifel cuts Janux Therapeutics target price to $34 from $35

Sylvamo Corp Q3 net income from continuing operations was $85 million